Literature DB >> 18444416

[Correlation of age and intraocular pressure with visual field damage in patients with normal-tension glaucoma].

Kenji Nakamoto1, Noriko Yasuda, Takumi Fukuda.   

Abstract

OBJECTIVE: We investigated the correlation of age and intraocular pressure (IOP) with visual field damage in patients with normal-tension glaucoma (NTG) and asymmetric visual field defects.
METHODS: A total of 88 NTG patients (176 eyes) were investigated. Patients in whom visual field defects were more severe in the eye with higher IOP than in the fellow eye were grouped as IOP-visual field-concordant patients, and the others as IOP-visual field-discordant patients. Mean 24-hour IOP was used as an indicator of IOP, and mean deviation (MD) as an indicator of visual field defects. Patients were also compared by age tertile.
RESULTS: The IOP-visual field-concordant group comprised 53 of the 88 patients (60.2%), among whom the >70-years tertile had significantly greater absolute values for MD asymmetry. In contrast, no significant differences in asymmetry by age tertile were seen in the IOP-visual field-discordant group.
CONCLUSION: Elevated IOP is a cause of visual field defects in many NTG patients. Among IOP-visual field-concordant patients, particular attention is required to visual field changes in the eyes of patients with higher IOP.

Entities:  

Mesh:

Year:  2008        PMID: 18444416

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  2 in total

1.  Assessment of intraocular pressure measured by Reichert Ocular Response Analyzer, Goldmann Applanation Tonometry, and Dynamic Contour Tonometry in healthy individuals.

Authors:  Ping-Bo Ouyang; Cong-Yi Li; Xiao-Hua Zhu; Xuan-Chu Duan
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

2.  Factors Related to a Right-Left Difference in Visual Field Defect in the Eyes with Untreated Normal Tension Glaucoma.

Authors:  Haruka Moroi; Ayako Anraku; Kyoko Ishida; Goji Tomita
Journal:  J Ophthalmol       Date:  2018-02-15       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.